CoChat

Oligodendrocytes: biology and pathology

Open access
Bradl, Monika, Lassmann, Hans · 2010 · Acta Neuropathologica

The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.

Abstract

Oligodendrocytes are the myelinating cells of the central nervous system (CNS). They are the end product of a cell lineage which has to undergo a complex and precisely timed program of proliferation, migration, differentiation, and myelination to finally produce the insulating sheath of axons. Due to this complex differentiation program, and due to their unique metabolism/physiology, oligodendrocytes count among the most vulnerable cells of the CNS. In this review, we first describe the different steps eventually culminating in the formation of mature oligodendrocytes and myelin sheaths, as they were revealed by studies in rodents. We will then show differences and similarities of human oligodendrocyte development. Finally, we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases, and we will reveal the different principles leading to the restoration of myelin sheaths or to a failure to do so.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-009-0601-5

Cites

223 of 223 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 a–d Detection of oligodendrocytes in paraffin embedded tissue sections. a Mouse cortex, stained by immunocytochemistry for CNPase shows numerous process bearing oligodendrocytes and staining of myelin sheaths, ×120; b high magnification of a CNPase positive oligodendrocyte in the mouse cortex (layer I), showing a small round cell body and few cell processes connected to myelin sheaths, ×1,000; c rat spinal cord stained by in situ hybridization for myelin basic protein mRNA; staining is seen in the cell bodies (e.g., in the gray matter) as well as in oligodendrocyte processes associated with myelin sheaths (dark staining in the white matter), ×50; d rat spinal cord stained by in situ hybridization for proteolipid protein (PLP); the mRNA for PLP is only located within the perinuclear cytoplasm, there is no staining of myelin, ×50; e–h oligodendrocyte pathology in transgenic animals overexpressing proteolipid protein; e and f hemizygous animal, which shows normal myelination, stained by immunocytochemistry for PLP; in the normal animal PLP protein is rarely detected in the cytoplasm of oligodendrocytes; in hemizygous PLP transgenic animals a variable extent of PLP expression is seen in the cytoplasm of oligodendrocytes (e), and this is associated with aberrant formation of myelin-like structures within and adjacent to the cells (f); g–h homozygous animal, which shows extensive dys-myelination; only few oligodendrocytes are preserved, which are connected to myelin sheaths and contain abundant PLP immunoreactivity in their cytoplasm (g); some of the PLP reactive oligodendrocytes show nuclear condensation and fragmentation, consistent with apoptosis (h), ×1,200; i–o neuropathology of progressive multifocal leukoencephalopathy; i multiple small confluent demyelinating lesions in the white and gray matter, giving the impression of a moth eaten pattern of demyelination (×2); k edge of an active demyelinating lesion with numerous macrophages, containing recent (luxol fast blue positive) degradation products; l and m pathologically altered nuclei in PML showing giant nuclei of astrocytes (l) and small oligodendrocyte nuclei with intranuclear inclusion (m); n and o similar nuclei, as shown in l and m contain virus antigen as revealed by immunocytochemistry; ×1,200
Fig. 1 a–d Detection of oligodendrocytes in paraffin embedded tissue sections. a Mouse cortex, stained by immunocytochemistry for CNPase shows numerous process bearing oligodendrocytes and staining of myelin sheaths, ×120; b high magnification of a CNPase positive oligodendrocyte in the mouse cortex (layer I), showing a small round cell body and few cell processes connected to myelin sheaths, ×1,000; c rat spinal cord stained by in situ hybridization for myelin basic protein mRNA; staining is seen in the cell bodies (e.g., in the gray matter) as well as in oligodendrocyte processes associated with myelin sheaths (dark staining in the white matter), ×50; d rat spinal cord stained by in situ hybridization for proteolipid protein (PLP); the mRNA for PLP is only located within the perinuclear cytoplasm, there is no staining of myelin, ×50; e–h oligodendrocyte pathology in transgenic animals overexpressing proteolipid protein; e and f hemizygous animal, which shows normal myelination, stained by immunocytochemistry for PLP; in the normal animal PLP protein is rarely detected in the cytoplasm of oligodendrocytes; in hemizygous PLP transgenic animals a variable extent of PLP expression is seen in the cytoplasm of oligodendrocytes (e), and this is associated with aberrant formation of myelin-like structures within and adjacent to the cells (f); g–h homozygous animal, which shows extensive dys-myelination; only few oligodendrocytes are preserved, which are connected to myelin sheaths and contain abundant PLP immunoreactivity in their cytoplasm (g); some of the PLP reactive oligodendrocytes show nuclear condensation and fragmentation, consistent with apoptosis (h), ×1,200; i–o neuropathology of progressive multifocal leukoencephalopathy; i multiple small confluent demyelinating lesions in the white and gray matter, giving the impression of a moth eaten pattern of demyelination (×2); k edge of an active demyelinating lesion with numerous macrophages, containing recent (luxol fast blue positive) degradation products; l and m pathologically altered nuclei in PML showing giant nuclei of astrocytes (l) and small oligodendrocyte nuclei with intranuclear inclusion (m); n and o similar nuclei, as shown in l and m contain virus antigen as revealed by immunocytochemistry; ×1,200CC BY-NC · PubMed Central
Fig. 2 Myelin and oligodendrocyte pathology in autoimmune encephalomyelitis, multiple sclerosis, and stroke. a–d Chronic autoimmune encephalomyelitis, induced in DA rat by active sensitization with MOG fusion protein; a massive demyelination is seen in the cerebellar white matter, ×6; b–d oligodendrocytes in different lesion stages of EAE; in the peri-plaque white matter myelin (red) is present and multiple oligodendrocytes with PLP mRNA (black) are seen (b); in the active lesions myelin falls apart, myelin fragments are taken up by macrophages (red granules) and oligodendrocytes are lost (c); in more advanced lesions no macrophages with early myelin degradation products are present; numerous oligodendrocytes re-appear in the lesions, apparently recruited from progenitor cells (black cells), followed by rapid and extensive remyelination; immunocytochemistry for PLP and in situ hybridization for PLP mRNA, ×1000; e–h chronic multiple sclerosis case with extensive remyelination within the CNS; This hemispheric brain section contains 3 active lesions, 4 demyelinated plaques, and 8 remyelinated shadow plaques, ×1.2; f–h double staining for PLP protein (red) and PLP mRNA (black) in one of the active lesions shows a similar pattern as described before in EAE; many oligodendrocytes in the peri-plaque white matter (f); oligodendrocyte loss in the zone of active demyelination (g) and reappearance of oligodendrocytes in the inactive zone, closely adjacent to the zone of activity (h), ×500; i–o myelin changes in the initial stage of a lesion in white matter stroke; LFB shows pale myelin staining (i); the axons, stained with Bielschowsky silver impregnation are largely preserved (k); MAG (l) and CNPase (m) are completely lost from the lesions, while the myelin proteins within the compact sheath (PLP; n) or on the oligodendrocyte surface (MOG; o) are preserved, ×20; p–s acute multiple sclerosis with lesions following a pattern of hypoxia-like tissue injury (Pattern III, [109]). p The section contains areas of initial demyelination (i), early active demyelination (a) and late active or inactive portions (d); q serial section of p, stained by immunocytochemistry for PLP; Only the late active and inactive lesions show loss of PLP; in the active portions (a) a minor loss of PLP reactivity is seen, while in the initial lesions PLP reactivity is the same as in the normal appearing white matter, ×3; r and s edge of an active lesion showing partial preservation of immunoreactivity for MOG (r), but extensive and complete loss of MAG(s), ×20
Fig. 2 Myelin and oligodendrocyte pathology in autoimmune encephalomyelitis, multiple sclerosis, and stroke. a–d Chronic autoimmune encephalomyelitis, induced in DA rat by active sensitization with MOG fusion protein; a massive demyelination is seen in the cerebellar white matter, ×6; b–d oligodendrocytes in different lesion stages of EAE; in the peri-plaque white matter myelin (red) is present and multiple oligodendrocytes with PLP mRNA (black) are seen (b); in the active lesions myelin falls apart, myelin fragments are taken up by macrophages (red granules) and oligodendrocytes are lost (c); in more advanced lesions no macrophages with early myelin degradation products are present; numerous oligodendrocytes re-appear in the lesions, apparently recruited from progenitor cells (black cells), followed by rapid and extensive remyelination; immunocytochemistry for PLP and in situ hybridization for PLP mRNA, ×1000; e–h chronic multiple sclerosis case with extensive remyelination within the CNS; This hemispheric brain section contains 3 active lesions, 4 demyelinated plaques, and 8 remyelinated shadow plaques, ×1.2; f–h double staining for PLP protein (red) and PLP mRNA (black) in one of the active lesions shows a similar pattern as described before in EAE; many oligodendrocytes in the peri-plaque white matter (f); oligodendrocyte loss in the zone of active demyelination (g) and reappearance of oligodendrocytes in the inactive zone, closely adjacent to the zone of activity (h), ×500; i–o myelin changes in the initial stage of a lesion in white matter stroke; LFB shows pale myelin staining (i); the axons, stained with Bielschowsky silver impregnation are largely preserved (k); MAG (l) and CNPase (m) are completely lost from the lesions, while the myelin proteins within the compact sheath (PLP; n) or on the oligodendrocyte surface (MOG; o) are preserved, ×20; p–s acute multiple sclerosis with lesions following a pattern of hypoxia-like tissue injury (Pattern III, [109]). p The section contains areas of initial demyelination (i), early active demyelination (a) and late active or inactive portions (d); q serial section of p, stained by immunocytochemistry for PLP; Only the late active and inactive lesions show loss of PLP; in the active portions (a) a minor loss of PLP reactivity is seen, while in the initial lesions PLP reactivity is the same as in the normal appearing white matter, ×3; r and s edge of an active lesion showing partial preservation of immunoreactivity for MOG (r), but extensive and complete loss of MAG(s), ×20CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. Cheepsunthorn P, Palmer C, Connor JR (1998) Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol 400:73–86 · doi:10.1002/(sici)1096-9861(19981012)400:1<73::aid-cne5>3.0.co;2-q
  2. Connor RR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83–93 · doi:10.1002/(sici)1098-1136(199606)17:2<83::aid-glia1>3.0.co;2-7
  3. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717 · DOI
  4. Schlesinger H (1909) Zur Frage der akuten Multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter. Arb Neurol Inst (Wien) 17:410–432

Cited by

See all 943

Metadata

Authors
Bradl, M., & Lassmann, H.
Affiliations
  • Medical University of Vienna (AT)
  • University of Vienna (AT)
Corresponding author
Bradl, Monika
Venue
Acta Neuropathologica
Published
2009-10-22
Volume
119
Issue
1
Pages
37-53
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2018558728
Cited by
933
References
221
Citations by year
2026: 66 · 2025: 67 · 2024: 85 · 2023: 69 · 2022: 74 · 2021: 84 · 2020: 61 · 2019: 72 · 2018: 50 · 2017: 46 · 2016: 44 · 2015: 39 · 2014: 41 · 2013: 51 · 2012: 28
FWCI
2.43
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Acta Neuropathologica (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Austrian Science Fund (P 19854)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
oligodendrocytes, myelination, myelin sheath, oligodendrocyte lineage, oligodendrocyte differentiation, demyelination, demyelinating disease, central nervous system
MeSH terms
Animals, Central Nervous System, Central Nervous System Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Species Specificity, Cell Death

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.